Copyright: ©Author(s) 2026.
Artif Intell Gastroenterol. Nov 8, 2026; 7(3): 127488
Published online Nov 8, 2026. doi: 10.35712/aig.127488
Published online Nov 8, 2026. doi: 10.35712/aig.127488
Table 2 Artificial intelligence methods and their current status in irritable bowel syndrome
| Method family | Core principle | Typical application | Current status in IBS |
| Supervised learning (random forest, support vector machine, gradient boosting) | Learns a mapping from labelled examples to a defined outcome | Diagnostic classification; treatment-response prediction | The most common approach; small single-centre cohorts, little external validation |
| Unsupervised learning (clustering, latent class and mixture models) | Identifies structure without predefined labels | Subtype and endotype discovery | Applied to microbiota and symptom subgrouping; subgroup stability sensitive to method |
| Deep learning - convolutional neural networks | Hierarchical feature learning from images | Endoscopic image analysis; optical histology prediction | Established in luminal endoscopy; minimal role in functional disease |
| Deep learning - recurrent networks and transformers | Models sequential or multi-modal data | Longitudinal risk prediction from clinical records | Demonstrated in general clinical records; no published IBS application |
| Natural language processing and large language models | Extracts structured information from free text | Symptom and outcome extraction from notes and narratives | Demonstrated in inflammatory bowel disease; not yet reported in IBS |
| Reinforcement learning | Optimises sequential decisions from outcome feedback | Adaptive treatment protocols | Conceptual only in IBS; demonstrated in critical care |
- Citation: Issa IA, Issa T. Role of artificial intelligence in irritable bowel syndrome: A narrative review. Artif Intell Gastroenterol 2026; 7(3): 127488
- URL: https://www.wjgnet.com/2644-3236/full/v7/i3/127488.htm
- DOI: https://dx.doi.org/10.35712/aig.127488